Corbus Pharmaceuticals
CRBP
$38.77
Share price
1.49%
Change (1 day)
344.61%
Change (1 year)
Categories
Corbus Pharmaceuticals (CRBP) - Total debt
Total debt on the balance sheet as of December 2023 : $20.88 M
According to Corbus Pharmaceuticals 's latest financial reports the company's total debt is $20.88 M. A company’s total debt is the sum of all current and non-current debts.
Corbus Pharmaceuticals - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $20.88 M | -16.76% |
| 2022-12-31 | $25.08 M | -5.65% |
| 2021-12-31 | $26.59 M | -0.92% |
| 2020-12-31 | $26.83 M | 184.11% |
| 2019-12-31 | $9.44 M | 2295.51% |
| 2018-12-31 | $0.39 M | 18.33% |
| 2017-12-31 | $0.33 M | 22.62% |
| 2016-12-31 | $0.27 M | 67.73% |
| 2015-12-31 | $0.16 M | 12.21% |
| 2014-12-31 | $0.14 M | -77.37% |
| 2013-12-31 | $0.63 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Viking Therapeutics
VKTX | $1.18 M | -94.35% | 🇺🇸 USA |
 Vanda Pharmaceuticals VNDA | $9.4 M | -54.97% | 🇺🇸 USA |
 Epizyme EPZM | N/A | N/A | 🇺🇸 USA |
 Advaxis ADXS | $8.31 M | -60.18% | 🇺🇸 USA |